Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma

A. Demeter, M. Abonyi, K. Y. Look, G. Keszler, M. Staub, G. Weber

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Thymidine kinase I (TK 1 EC. 2.7.1.21) the most specific and cell-cycle regulated salvage enzyme for pyrimidine nucleoside supply of DNA synthesis is a promising target to rationally designed chemo- and other therapies. The present study was undertaken to compare the heat stability of TK isoenzymes of both normal ovarian and epithelial ovarian cancer cells. Tissue extracts of epithelial ovarian carcinomas (N = 7) and normal ovaries (N=9) were analyzed for thymidine kinase activity using the polyethyleneimine-cellulose disc radioassay. The TK activity in extracts of ovarian carcinomas was 12-fold higher than in extracts of normal ovaries. The TK activity of ovarian carcinomas decreased significantly even after 30 minutes incubation at 37°C while, the enzyme activity of normal ovarian extracts was more stable and decreased to the same extent after 120 minutes. The half-life time of the enzyme activy was 82 min in the normal but only 36 minutes in the cancer tissue extract at 37°C. Conclusion: The TK activity of malignant ovarian cells was much higher but more unstable (t1/2=36 minutes) than the enzyme isolated firm healthy ovaries (t1/2=82 minutes). This profound difference in thermostability might provide the molecular background for hyperthermia combined with chemotherapy as a promising treatment for ovarian malignancies.

Original languageEnglish
Pages (from-to)353-358
Number of pages6
JournalAnticancer Research
Volume21
Issue number1 A
Publication statusPublished - 2001

Fingerprint

Thymidine Kinase
Isoenzymes
Ovary
Carcinoma
Tissue Extracts
Enzymes
Pyrimidine Nucleosides
Half-Life
Neoplasms
Cell Cycle
Fever
Hot Temperature
Drug Therapy
DNA
Therapeutics
Ovarian epithelial cancer

Keywords

  • Heat-sensitivity
  • Hyperthermy
  • Ovarian cancer
  • Thymidine kinase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Demeter, A., Abonyi, M., Look, K. Y., Keszler, G., Staub, M., & Weber, G. (2001). Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma. Anticancer Research, 21(1 A), 353-358.

Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma. / Demeter, A.; Abonyi, M.; Look, K. Y.; Keszler, G.; Staub, M.; Weber, G.

In: Anticancer Research, Vol. 21, No. 1 A, 2001, p. 353-358.

Research output: Contribution to journalArticle

Demeter, A, Abonyi, M, Look, KY, Keszler, G, Staub, M & Weber, G 2001, 'Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma', Anticancer Research, vol. 21, no. 1 A, pp. 353-358.
Demeter, A. ; Abonyi, M. ; Look, K. Y. ; Keszler, G. ; Staub, M. ; Weber, G. / Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma. In: Anticancer Research. 2001 ; Vol. 21, No. 1 A. pp. 353-358.
@article{ee65eda2c49c4c9fab4dfe8d6d674181,
title = "Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma",
abstract = "Thymidine kinase I (TK 1 EC. 2.7.1.21) the most specific and cell-cycle regulated salvage enzyme for pyrimidine nucleoside supply of DNA synthesis is a promising target to rationally designed chemo- and other therapies. The present study was undertaken to compare the heat stability of TK isoenzymes of both normal ovarian and epithelial ovarian cancer cells. Tissue extracts of epithelial ovarian carcinomas (N = 7) and normal ovaries (N=9) were analyzed for thymidine kinase activity using the polyethyleneimine-cellulose disc radioassay. The TK activity in extracts of ovarian carcinomas was 12-fold higher than in extracts of normal ovaries. The TK activity of ovarian carcinomas decreased significantly even after 30 minutes incubation at 37°C while, the enzyme activity of normal ovarian extracts was more stable and decreased to the same extent after 120 minutes. The half-life time of the enzyme activy was 82 min in the normal but only 36 minutes in the cancer tissue extract at 37°C. Conclusion: The TK activity of malignant ovarian cells was much higher but more unstable (t1/2=36 minutes) than the enzyme isolated firm healthy ovaries (t1/2=82 minutes). This profound difference in thermostability might provide the molecular background for hyperthermia combined with chemotherapy as a promising treatment for ovarian malignancies.",
keywords = "Heat-sensitivity, Hyperthermy, Ovarian cancer, Thymidine kinase",
author = "A. Demeter and M. Abonyi and Look, {K. Y.} and G. Keszler and M. Staub and G. Weber",
year = "2001",
language = "English",
volume = "21",
pages = "353--358",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 A",

}

TY - JOUR

T1 - Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma

AU - Demeter, A.

AU - Abonyi, M.

AU - Look, K. Y.

AU - Keszler, G.

AU - Staub, M.

AU - Weber, G.

PY - 2001

Y1 - 2001

N2 - Thymidine kinase I (TK 1 EC. 2.7.1.21) the most specific and cell-cycle regulated salvage enzyme for pyrimidine nucleoside supply of DNA synthesis is a promising target to rationally designed chemo- and other therapies. The present study was undertaken to compare the heat stability of TK isoenzymes of both normal ovarian and epithelial ovarian cancer cells. Tissue extracts of epithelial ovarian carcinomas (N = 7) and normal ovaries (N=9) were analyzed for thymidine kinase activity using the polyethyleneimine-cellulose disc radioassay. The TK activity in extracts of ovarian carcinomas was 12-fold higher than in extracts of normal ovaries. The TK activity of ovarian carcinomas decreased significantly even after 30 minutes incubation at 37°C while, the enzyme activity of normal ovarian extracts was more stable and decreased to the same extent after 120 minutes. The half-life time of the enzyme activy was 82 min in the normal but only 36 minutes in the cancer tissue extract at 37°C. Conclusion: The TK activity of malignant ovarian cells was much higher but more unstable (t1/2=36 minutes) than the enzyme isolated firm healthy ovaries (t1/2=82 minutes). This profound difference in thermostability might provide the molecular background for hyperthermia combined with chemotherapy as a promising treatment for ovarian malignancies.

AB - Thymidine kinase I (TK 1 EC. 2.7.1.21) the most specific and cell-cycle regulated salvage enzyme for pyrimidine nucleoside supply of DNA synthesis is a promising target to rationally designed chemo- and other therapies. The present study was undertaken to compare the heat stability of TK isoenzymes of both normal ovarian and epithelial ovarian cancer cells. Tissue extracts of epithelial ovarian carcinomas (N = 7) and normal ovaries (N=9) were analyzed for thymidine kinase activity using the polyethyleneimine-cellulose disc radioassay. The TK activity in extracts of ovarian carcinomas was 12-fold higher than in extracts of normal ovaries. The TK activity of ovarian carcinomas decreased significantly even after 30 minutes incubation at 37°C while, the enzyme activity of normal ovarian extracts was more stable and decreased to the same extent after 120 minutes. The half-life time of the enzyme activy was 82 min in the normal but only 36 minutes in the cancer tissue extract at 37°C. Conclusion: The TK activity of malignant ovarian cells was much higher but more unstable (t1/2=36 minutes) than the enzyme isolated firm healthy ovaries (t1/2=82 minutes). This profound difference in thermostability might provide the molecular background for hyperthermia combined with chemotherapy as a promising treatment for ovarian malignancies.

KW - Heat-sensitivity

KW - Hyperthermy

KW - Ovarian cancer

KW - Thymidine kinase

UR - http://www.scopus.com/inward/record.url?scp=0035062014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035062014&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 353

EP - 358

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 A

ER -